Resa Schlossberg

Partner and Head of Intellectual Property and Technology Transactions at Skadden

Speaker

Ms. Schlossberg structures, drafts, negotiates and advises on joint ventures, strategic alliances, mergers and acquisitions, and agreements such as license, research and development (R&D), collaboration, co-marketing and co-promotion, manufacturing and supply, R&D funding, synthetic royalty deals and consulting. She also conducts IP diligence and evaluates technologies for clients, including pharmaceutical, chemical, biotechnology, cosmetic, medical device and renewable energy companies, among others.

In addition to transactional work, Ms. Schlossberg has significant experience litigating patent infringement disputes in U.S. federal court, representing clients in false advertising and consumer deception matters and counseling on various strategic IP issues. She is a registered patent attorney with the U.S. Patent and Trademark Office.

Ms. Schlossberg has been repeatedly named one of the Top 250 Women in IP and a Transactions Star by Managing IP, recognized among LMG Life Sciences’ top practitioners for Licensing & Collaboration and Mergers & Acquisitions, and selected to Intellectual Asset Management’s IAM Patent 1000, where she is described as a “master at executing a deep dive into target and competitor portfolios, formulating strategies, structuring deals and successfully negotiating them.” She has also been recognized in Chambers USA and named one of Lawdragon’s 500 Leading Lawyers in America, 500 Leading Global IP Lawyers and 500 Leading Dealmakers in America.